SHPH
Shuttle Pharmaceuticals Inc
NASDAQ: SHPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.24
+0.58% today
Updated 2026-10-28
Market cap
$22.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-16.87
Dividend yield
—
52W range
$3 – $36
Volume
0.0M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C4.5
Quality
C3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-10.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -10.55 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-603640.00
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-5.00M | $-6.59M | $-9.14M | $-11.72M | $-3.15M |
| EPS | — | — | — | — | $-16.87 |
| Free cash flow | $-2.71M | $-5.60M | $-7.35M | $-9.48M | $-603640.00 |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Shuttle Pharmaceuticals Inc trades at $5.24. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -10.55, it sits in the distress.
Frequently asked questions
What is Shuttle Pharmaceuticals Inc's stock price?
Shuttle Pharmaceuticals Inc (SHPH) trades at $5.24.
Is Shuttle Pharmaceuticals Inc overvalued?
Shuttle Pharmaceuticals Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Shuttle Pharmaceuticals Inc's Altman Z-Score is -10.55, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-323.38%
Beta1.14
50D MA$4.03
200D MA$7.56
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—